Ranbaxy Laboratories: The Winning Chemistry



IBS CDC IBS CDC IBS CDC IBS CDC RSS Feed

Code : COM0043

Year :
2004

Industry : Health Care

Region : UK

Teaching Note:Not Available

Structured Assignment :Not Available

Buy This Case Study        

<< Previous

The Indian Pharmaceutical Industry "The Indian pharmaceutical industry is a success story providing employment formillions and ensuring that essential drugs at affordable prices are available to the vast population of this sub-continent. However, the new 'trade' rules of the World Trade Organization now pose a serious threat to the industry and to themillions who are dependent on it for their health and livelihood"...

Genesis and Growth of Ranbaxy Incorporated in 1961, Ranbaxy commenced formulations manufacturing and operations only a year later when Bhai Mohan Singh (Bhai Mohan) had an agreement with Lepetit SpA (Milan) to produce chlorophenicol (a typhoid drug for which Lepetit held a patent then) in India. In 1967, Dr. Parvinder Singh (s/o Bhai Mohan Singh and a Ph.D. from the University of Michigan) joined the company and eventually bought out Lepetit's stakes...

Ranbaxy's Prescription for Growth As of 2004, Ranbaxy together with its subsidiaries operated as an integrated international pharmaceutical organization with businesses encompassing the entire value chain in the marketing, production and distribution of dosage forms and APIs. Ranbaxy was also engaged in the business of diagnostics, animal healthcare products, laboratory reagents, fine chemicals and consumer healthcare products...

For Case Books Click Here >>

For Case eBooks Click Here >>





Contact us: IBS Case Development Centre (IBSCDC), IFHE Campus, Donthanapally, Sankarapally Road, Hyderabad-501203, Telangana, INDIA.
Mob: +91- 9640901313,
E-mail: casehelpdesk@ibsindia.org

2020-2025 IBS Case Development Centre. All rights reserved. | Careers | Privacy Policy | Terms of Use | Disclosure | Site Map xml sitemap